Intrinsic value of AMN Healthcare Services - AMN

Previous Close

$37.50

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$37.50

 
Intrinsic value premium content
 
Up/down potential premium content
 
Rating premium content
 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of AMN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  30.01
  21.10
  19.49
  18.04
  16.74
  15.56
  14.51
  13.56
  12.70
  11.93
  11.24
  10.61
  10.05
  9.55
  9.09
  8.68
  8.31
  7.98
  7.69
  7.42
  7.17
  6.96
  6.76
  6.59
  6.43
  6.28
  6.16
  6.04
  5.94
  5.84
  5.76
Revenue, $m
  1,902
  2,303
  2,752
  3,249
  3,793
  4,383
  5,019
  5,699
  6,423
  7,189
  7,997
  8,846
  9,735
  10,664
  11,634
  12,644
  13,695
  14,789
  15,925
  17,106
  18,334
  19,609
  20,935
  22,314
  23,748
  25,240
  26,794
  28,412
  30,099
  31,857
  33,692
Variable operating expenses, $m
 
  1,971
  2,349
  2,766
  3,224
  3,720
  4,255
  4,827
  5,436
  6,080
  6,760
  7,439
  8,187
  8,969
  9,784
  10,634
  11,518
  12,437
  13,393
  14,387
  15,419
  16,492
  17,607
  18,766
  19,972
  21,227
  22,534
  23,895
  25,314
  26,793
  28,335
Fixed operating expenses, $m
 
  82
  84
  86
  88
  91
  93
  95
  97
  100
  102
  105
  108
  110
  113
  116
  119
  122
  125
  128
  131
  134
  138
  141
  145
  148
  152
  156
  160
  164
  168
Total operating expenses, $m
  1,711
  2,053
  2,433
  2,852
  3,312
  3,811
  4,348
  4,922
  5,533
  6,180
  6,862
  7,544
  8,295
  9,079
  9,897
  10,750
  11,637
  12,559
  13,518
  14,515
  15,550
  16,626
  17,745
  18,907
  20,117
  21,375
  22,686
  24,051
  25,474
  26,957
  28,503
Operating income, $m
  192
  250
  319
  396
  480
  572
  671
  777
  889
  1,009
  1,135
  1,301
  1,440
  1,585
  1,737
  1,894
  2,059
  2,229
  2,407
  2,592
  2,784
  2,983
  3,191
  3,406
  3,631
  3,864
  4,108
  4,361
  4,625
  4,901
  5,189
EBITDA, $m
  222
  302
  375
  456
  544
  640
  744
  855
  974
  1,099
  1,231
  1,370
  1,516
  1,668
  1,827
  1,993
  2,165
  2,344
  2,531
  2,725
  2,926
  3,136
  3,353
  3,580
  3,815
  4,061
  4,316
  4,582
  4,860
  5,149
  5,451
Interest expense (income), $m
  8
  13
  18
  24
  31
  38
  46
  55
  64
  74
  84
  95
  106
  118
  131
  144
  158
  172
  187
  202
  218
  234
  252
  270
  288
  308
  328
  349
  371
  393
  417
Earnings before tax, $m
  176
  237
  301
  372
  450
  534
  625
  722
  826
  935
  1,051
  1,206
  1,334
  1,467
  1,606
  1,750
  1,901
  2,058
  2,220
  2,390
  2,566
  2,749
  2,939
  3,137
  3,342
  3,557
  3,780
  4,012
  4,255
  4,508
  4,771
Tax expense, $m
  70
  64
  81
  100
  121
  144
  169
  195
  223
  252
  284
  326
  360
  396
  434
  473
  513
  556
  600
  645
  693
  742
  793
  847
  902
  960
  1,021
  1,083
  1,149
  1,217
  1,288
Net income, $m
  106
  173
  220
  272
  328
  390
  456
  527
  603
  683
  767
  881
  974
  1,071
  1,172
  1,278
  1,388
  1,502
  1,621
  1,744
  1,873
  2,006
  2,145
  2,290
  2,440
  2,596
  2,759
  2,929
  3,106
  3,291
  3,483

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  11
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  1,187
  1,424
  1,702
  2,009
  2,345
  2,710
  3,104
  3,524
  3,972
  4,446
  4,945
  5,470
  6,020
  6,595
  7,195
  7,819
  8,470
  9,146
  9,849
  10,579
  11,338
  12,127
  12,947
  13,799
  14,686
  15,609
  16,570
  17,571
  18,614
  19,701
  20,836
Adjusted assets (=assets-cash), $m
  1,176
  1,424
  1,702
  2,009
  2,345
  2,710
  3,104
  3,524
  3,972
  4,446
  4,945
  5,470
  6,020
  6,595
  7,195
  7,819
  8,470
  9,146
  9,849
  10,579
  11,338
  12,127
  12,947
  13,799
  14,686
  15,609
  16,570
  17,571
  18,614
  19,701
  20,836
Revenue / Adjusted assets
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
  1.617
Average production assets, $m
  266
  322
  385
  455
  531
  614
  703
  798
  899
  1,006
  1,120
  1,238
  1,363
  1,493
  1,629
  1,770
  1,917
  2,070
  2,230
  2,395
  2,567
  2,745
  2,931
  3,124
  3,325
  3,534
  3,751
  3,978
  4,214
  4,460
  4,717
Working capital, $m
  176
  205
  245
  289
  338
  390
  447
  507
  572
  640
  712
  787
  866
  949
  1,035
  1,125
  1,219
  1,316
  1,417
  1,522
  1,632
  1,745
  1,863
  1,986
  2,114
  2,246
  2,385
  2,529
  2,679
  2,835
  2,999
Total debt, $m
  363
  514
  687
  879
  1,089
  1,316
  1,562
  1,824
  2,104
  2,399
  2,711
  3,038
  3,382
  3,740
  4,114
  4,504
  4,910
  5,332
  5,770
  6,226
  6,700
  7,192
  7,704
  8,236
  8,789
  9,365
  9,965
  10,589
  11,240
  11,919
  12,627
Total liabilities, $m
  738
  889
  1,062
  1,254
  1,464
  1,691
  1,937
  2,199
  2,479
  2,774
  3,086
  3,413
  3,757
  4,115
  4,489
  4,879
  5,285
  5,707
  6,145
  6,601
  7,075
  7,567
  8,079
  8,611
  9,164
  9,740
  10,340
  10,964
  11,615
  12,294
  13,002
Total equity, $m
  449
  536
  640
  755
  882
  1,019
  1,167
  1,325
  1,493
  1,672
  1,859
  2,057
  2,264
  2,480
  2,705
  2,940
  3,185
  3,439
  3,703
  3,978
  4,263
  4,560
  4,868
  5,189
  5,522
  5,869
  6,230
  6,607
  6,999
  7,408
  7,834
Total liabilities and equity, $m
  1,187
  1,425
  1,702
  2,009
  2,346
  2,710
  3,104
  3,524
  3,972
  4,446
  4,945
  5,470
  6,021
  6,595
  7,194
  7,819
  8,470
  9,146
  9,848
  10,579
  11,338
  12,127
  12,947
  13,800
  14,686
  15,609
  16,570
  17,571
  18,614
  19,702
  20,836
Debt-to-equity ratio
  0.808
  0.960
  1.070
  1.160
  1.230
  1.290
  1.340
  1.380
  1.410
  1.440
  1.460
  1.480
  1.490
  1.510
  1.520
  1.530
  1.540
  1.550
  1.560
  1.570
  1.570
  1.580
  1.580
  1.590
  1.590
  1.600
  1.600
  1.600
  1.610
  1.610
  1.610
Adjusted equity ratio
  0.372
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376
  0.376

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  106
  173
  220
  272
  328
  390
  456
  527
  603
  683
  767
  881
  974
  1,071
  1,172
  1,278
  1,388
  1,502
  1,621
  1,744
  1,873
  2,006
  2,145
  2,290
  2,440
  2,596
  2,759
  2,929
  3,106
  3,291
  3,483
Depreciation, amort., depletion, $m
  30
  52
  56
  59
  64
  68
  73
  79
  84
  90
  96
  69
  76
  83
  90
  98
  107
  115
  124
  133
  143
  153
  163
  174
  185
  196
  208
  221
  234
  248
  262
Funds from operations, $m
  115
  225
  276
  331
  392
  458
  529
  606
  687
  773
  863
  949
  1,049
  1,154
  1,263
  1,376
  1,494
  1,617
  1,745
  1,878
  2,016
  2,159
  2,308
  2,463
  2,625
  2,793
  2,968
  3,150
  3,340
  3,538
  3,745
Change in working capital, $m
  -17
  36
  40
  44
  48
  53
  57
  61
  64
  68
  72
  76
  79
  83
  86
  90
  94
  97
  101
  105
  109
  114
  118
  123
  128
  133
  138
  144
  150
  157
  163
Cash from operations, $m
  132
  230
  236
  287
  344
  406
  473
  545
  622
  705
  792
  874
  970
  1,071
  1,176
  1,286
  1,401
  1,520
  1,644
  1,772
  1,906
  2,045
  2,190
  2,341
  2,497
  2,660
  2,829
  3,006
  3,190
  3,382
  3,582
Maintenance CAPEX, $m
  0
  -15
  -18
  -21
  -25
  -29
  -34
  -39
  -44
  -50
  -56
  -62
  -69
  -76
  -83
  -90
  -98
  -107
  -115
  -124
  -133
  -143
  -153
  -163
  -174
  -185
  -196
  -208
  -221
  -234
  -248
New CAPEX, $m
  -22
  -57
  -63
  -70
  -76
  -83
  -89
  -95
  -101
  -107
  -113
  -119
  -124
  -130
  -136
  -141
  -147
  -153
  -159
  -165
  -172
  -179
  -186
  -193
  -201
  -209
  -218
  -227
  -236
  -246
  -257
Cash from investing activities, $m
  -257
  -72
  -81
  -91
  -101
  -112
  -123
  -134
  -145
  -157
  -169
  -181
  -193
  -206
  -219
  -231
  -245
  -260
  -274
  -289
  -305
  -322
  -339
  -356
  -375
  -394
  -414
  -435
  -457
  -480
  -505
Free cash flow, $m
  -125
  158
  155
  196
  242
  293
  350
  411
  477
  547
  623
  693
  777
  865
  958
  1,054
  1,155
  1,260
  1,369
  1,483
  1,601
  1,724
  1,852
  1,985
  2,123
  2,266
  2,416
  2,571
  2,733
  2,902
  3,077
Issuance/(repayment) of debt, $m
  150
  155
  173
  192
  210
  228
  245
  263
  279
  296
  312
  328
  343
  359
  374
  390
  406
  422
  439
  456
  474
  492
  512
  532
  553
  576
  600
  625
  651
  679
  708
Issuance/(repurchase) of shares, $m
  -13
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  126
  155
  173
  192
  210
  228
  245
  263
  279
  296
  312
  328
  343
  359
  374
  390
  406
  422
  439
  456
  474
  492
  512
  532
  553
  576
  600
  625
  651
  679
  708
Total cash flow (excl. dividends), $m
  1
  313
  328
  388
  452
  521
  595
  673
  756
  843
  934
  1,020
  1,120
  1,224
  1,332
  1,444
  1,561
  1,682
  1,808
  1,939
  2,075
  2,217
  2,364
  2,517
  2,676
  2,842
  3,015
  3,196
  3,384
  3,580
  3,785
Retained Cash Flow (-), $m
  -101
  -94
  -104
  -115
  -126
  -137
  -148
  -158
  -168
  -178
  -188
  -197
  -207
  -216
  -225
  -235
  -244
  -254
  -264
  -275
  -285
  -297
  -308
  -321
  -333
  -347
  -361
  -376
  -392
  -409
  -427
Prev. year cash balance distribution, $m
 
  7
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  227
  224
  272
  326
  384
  447
  515
  588
  665
  746
  823
  913
  1,008
  1,106
  1,209
  1,316
  1,428
  1,544
  1,664
  1,790
  1,920
  2,055
  2,196
  2,343
  2,495
  2,654
  2,819
  2,992
  3,171
  3,359
Discount rate, %
 
  5.90
  6.20
  6.50
  6.83
  7.17
  7.53
  7.91
  8.30
  8.72
  9.15
  9.61
  10.09
  10.60
  11.13
  11.68
  12.27
  12.88
  13.52
  14.20
  14.91
  15.65
  16.44
  17.26
  18.12
  19.03
  19.98
  20.98
  22.03
  23.13
  24.29
PV of cash for distribution, $m
 
  214
  198
  225
  250
  272
  289
  302
  311
  313
  311
  300
  288
  272
  253
  231
  207
  182
  157
  134
  111
  91
  72
  56
  43
  32
  23
  16
  11
  8
  5
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services in the United States. The company operates through three segments: Nurse and Allied Solutions, Locum Tenens Solutions, and Other Workforce Solutions. Its services include travel nurse staffing under the American Mobile, Onward Healthcare, Nurses Rx, and O’Grady-Peyton brands; rapid response nurse staffing and labor disruption services, a shorter-term staffing solution for four to eight weeks under the NurseChoice brand; local, or per diem, staffing for daily shift work or on as-needed basis under the Nursefinders brand; and locum tenens staffing for specialties, clinicians, and dentists on an independent contractor basis on temporary assignments from a few days up to one year under the Staff Care and Locum Leaders brands. The company also offers allied staffing on a travel and local staffing basis under the Med Travelers and Club Staffing brands; physician permanent placement services under the Merritt Hawkins, MillicanSolutions, and Kendall & Davis brands to hospitals, healthcare facilities, and physician practice groups; vendor management systems, including ShiftWise and Medefis technologies; recruitment process outsourcing for permanent staffing; and workforce optimization services comprising consulting, data analytics, predictive modeling, and SaaS-based scheduling technology under the Smart Square brand, as well as interim leadership staffing and executive search services, and managed services programs. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in San Diego, California.

FINANCIAL RATIOS  of  AMN Healthcare Services (AMN)

Valuation Ratios
P/E Ratio 16.8
Price to Sales 0.9
Price to Book 4
Price to Tangible Book
Price to Cash Flow 13.5
Price to Free Cash Flow 16.2
Growth Rates
Sales Growth Rate 30%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -18.5%
Cap. Spend. - 3 Yr. Gr. Rate 19.6%
Financial Strength
Quick Ratio 3
Current Ratio 0.1
LT Debt to Equity 80%
Total Debt to Equity 80.8%
Interest Coverage 23
Management Effectiveness
Return On Assets 10.7%
Ret/ On Assets - 3 Yr. Avg. 9.1%
Return On Total Capital 16.4%
Ret/ On T. Cap. - 3 Yr. Avg. 14.5%
Return On Equity 26.6%
Return On Equity - 3 Yr. Avg. 22.5%
Asset Turnover 1.8
Profitability Ratios
Gross Margin 32.6%
Gross Margin - 3 Yr. Avg. 31.7%
EBITDA Margin 11.3%
EBITDA Margin - 3 Yr. Avg. 9.7%
Operating Margin 10%
Oper. Margin - 3 Yr. Avg. 8.4%
Pre-Tax Margin 9.3%
Pre-Tax Margin - 3 Yr. Avg. 7.7%
Net Profit Margin 5.6%
Net Profit Margin - 3 Yr. Avg. 4.8%
Effective Tax Rate 39.8%
Eff/ Tax Rate - 3 Yr. Avg. 38.7%
Payout Ratio 0%

AMN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the AMN stock intrinsic value calculation we used $1902 million for the last fiscal year's total revenue generated by AMN Healthcare Services. The default revenue input number comes from 2016 income statement of AMN Healthcare Services. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our AMN stock valuation model: a) initial revenue growth rate of 21.1% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 5.9%, whose default value for AMN is calculated based on our internal credit rating of AMN Healthcare Services, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of AMN Healthcare Services.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of AMN stock the variable cost ratio is equal to 85.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $80 million in the base year in the intrinsic value calculation for AMN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for AMN Healthcare Services.

Corporate tax rate of 27% is the nominal tax rate for AMN Healthcare Services. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the AMN stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for AMN are equal to 14%.

Life of production assets of 18 years is the average useful life of capital assets used in AMN Healthcare Services operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for AMN is equal to 8.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $449 million for AMN Healthcare Services - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 47.101 million for AMN Healthcare Services is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of AMN Healthcare Services at the current share price and the inputted number of shares is $1.8 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
AMN AMN Healthcare 37.50 prem.  prem.
CCRN Cross Country 12.83 prem.  prem.
PINC Premier 35.35 prem.  prem.
HCA HCA Holdings 86.24 prem.  prem.
KELYA Kelly Services 22.21 prem.  prem.
Q Quintiles IMS 91.08 prem.  prem.
ASGN On Assignment 54.13 prem.  prem.
GEN Genesis Health 1.88 prem.  prem.

COMPANY NEWS

▶ AMN Healthcare tops Street 1Q forecasts   [05:02AM  Associated Press]
▶ AMN Healthcare Announces First Quarter 2017 Results   [May-04-17 04:21PM  PR Newswire]
▶ Locum Leaders Names Bonnie Britton as President   [Dec-19-16 11:00AM  PR Newswire]
▶ President-elect Trump puts Obamacares future up in the air   [Nov-10-16 09:46AM  at MarketWatch]
▶ AMN Healthcare Keeps Looking Healthier   [08:32AM  at Motley Fool]
Stock chart of AMN Financial statements of AMN Annual reports of AMN
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.